Shortcut to Body
  1. HOME
  2. All KODEX ETFs
  3. Product Details

Asset type Leveraged/Inverse

Kodex China H Leverage(H)(204450)

Double performance in China investments!! Realize double performance on a daily basis following HSCEI movements.

Last data obtained Quotes delayed at least 20 minutes. Market data provided by KOSCOM.

  • Current Price (KRW)

    1,514

    up 69 (4.78%)

  • iNAV (KRW)

    1,526

    up 131 (9.38%)

  • Trading Volume (shares)

    1,442,477

About Product

* as of Apr 23, 2024

Benchmark Index

Hang Seng China Enterprises Index

The Hanf Seng China Enterprises Index ("HSCEI") reflects the overall performance of Mainland China securities listed in Hong Kong. By selecting only the largest and most liquid securities, the index offers high market value coverage over HK-listed Mainland securities.

View index information in detail

Key Facts

Basic Information - Net Assets, Benchmark Index, Gross Expense Ratio, Dividend, Benchmark Index, Base Currency, General Administrator, Trustee
Net Assets 71 (billion) Base Currency KRW
Inception Date September 12, 2014 General
Administrator
Shinhan Aitas
Gross Expense
Ratio
0.64%
(AP : 0.001%, Manager Fee :0.559%, Trustee Fee :0.04%, General Administrator Fee :0.04%)
Trustee KB Bank
Dividend No dividend distribution Related
Documents
-
  • Carefully consider the Funds' investment objectives, risk factors, and charges and expenses before investing.
  • Collective investment schemes are not insured by the Korea Deposit Insurance Corporation.
  • The performance quoted represents past performance and does not guarantee future results.
  • Investment return and principal value will fluctuate, so you may have a gain or loss when shares are sold.
  • Current performance may be lower or higher than the performance quoted.
  • This information is not warranted to be accurate, complete, or timely.
  • Neither KOSCOM nor Samsung Asset Management is responsible for any damages or losses arising from any use of the information on this website.
  • This website is made in the Korean language, and if there shall arise any conflict between the Korean version and any translation thereof,
    including this -English translation, the Korean version shall prevail.